The Role of Caffeine in Noninvasive Respiratory Support
- PMID: 27837758
- PMCID: PMC5111868
- DOI: 10.1016/j.clp.2016.07.011
The Role of Caffeine in Noninvasive Respiratory Support
Abstract
Caffeine is one of the most commonly prescribed medications in preterm neonates and is widely used to treat or prevent apnea of prematurity. Caffeine therapy is safe, effectively decreases apnea, and improves short- and long-term outcomes in preterm infants. In this review, the authors summarize the role of caffeine therapy for preterm infants receiving noninvasive respiratory support. As caffeine is already widely used, recent data are summarized that may guide clinicians in optimizing the use of caffeine therapy, with a review of the timing of initiation, dose, and duration of therapy.
Keywords: Apnea; Bronchopulmonary dysplasia; Caffeine; Noninvasive ventilation; Premature infant.
Copyright © 2016 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors have no relevant conflicts of interest.
Figures
References
-
- Dobson NR, Hunt CE. Pharmacology Review: Caffeine Use in Neonates: Indications, Pharmacokinetics, Clinical Effects, Outcomes. NeoReviews. 2003;14:e540–e550.
-
- Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006;117(6):1979–1987. - PubMed
-
- Abu-Shaweesh JM, Martin RJ. Neonatal apnea: what's new? Pediatr Pulmonol. 2008;43(10):937–944. - PubMed
-
- Martin RJ, Di Fiore JM, Macfarlane PM, Wilson CG. Physiologic basis for intermittent hypoxic episodes in preterm infants. Adv Exp Med Biol. 2012;758:351–358. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
